Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Campath Could Be Approved For Multiple Sclerosis By 2009, Genzyme Says

Oct 18 2005

• By Christopher Hollis

Related Content

Genzyme/Schering AG To Initiate Campath Phase III Trial For MS

Sep 16 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window